Unique ID issued by UMIN | UMIN000048031 |
---|---|
Receipt number | R000054745 |
Scientific Title | Effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients: A Randomized Clinical Trial |
Date of disclosure of the study information | 2022/06/25 |
Last modified on | 2022/06/13 18:49:00 |
Effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients: A Randomized Clinical Trial
BETA CELL FUNCTION OR INSULIN SECRETION (HOMA B)
The amount of glucose cleared from the blood in response to a dose of insulin. A score of less than 100 defined reduced B cell function.
INSULIN RESISTANCE (HOMA IR)
Defined as a condition when normal amount of insulin in body fails to produce the desired response . A score of greater than or equal to 2.0 defined IR.
INSULIN SENSITIVITY
Insulin sensitivity calculate by using the following formula is IS equal to 1 per IR (Normal is less than 3.0)
VITAMIN D STATUS
Vitamin D status was defined as SUFFICIENT with level of vitamin D greater than 30ng per ml and DEFICIENT with level of serum 25 (OH) vit D less than or equal to 30ng per ml.
Effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients: A Randomized Clinical Trial
BETA CELL FUNCTION OR INSULIN SECRETION (HOMA B)
The amount of glucose cleared from the blood in response to a dose of insulin. A score of less than 100 defined reduced B cell function.
INSULIN RESISTANCE (HOMA IR)
Defined as a condition when normal amount of insulin in body fails to produce the desired response . A score of greater than or equal to 2.0 defined IR.
INSULIN SENSITIVITY
Insulin sensitivity calculate by using the following formula is IS equal to 1 per IR (Normal is less than 3.0)
VITAMIN D STATUS
Vitamin D status was defined as SUFFICIENT with level of vitamin D greater than 30ng per ml and DEFICIENT with level of serum 25 (OH) vit D less than or equal to 30ng per ml.
Asia(except Japan) |
Type 2 Diabetic patients
Endocrinology and Metabolism | Adult |
Others
YES
To examine the effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients by comparing treatment and control group both at baseline and end line
Others
SPECIFIC OBJECTIVES (FOR BOTH TREATMENT AND CONTROL GROUP)
1. Assessment of the socio-demographic characteristics
2. Assessment of nutritional status with anthropometric parameters.
3. Advising, monitoring and controlling the diabetes diet and physical activity.
4. Analyzing different biochemical profile -
- Vitamin D
- Fasting Blood Glucose (FBG)
- Fasting blood insulin (FBI)
- Derived parameter Homeostatic model assessment (HOMA) for beta-cell function, Insulin sensitivity (IS) and insulin resistance (IR)
- HbA1c (Glycated Haemoglobin A1C)
- Serum calcium
- C-reactive protein (CRP)
- MDA (malondialdehyde) and
- SOD (Superoxide dismutase)
5. To find out the influence of vitamin D on
- Fasting blood Insulin (FBI) level
- Fasting blood glucose (FBG) level
- Glycated hemoglobin (HbA1c or A1c) level
- Stress-marker like Malondialdehyde (MDA) and Super-oxide Dismutase level (SOD)
- Serum Calcium and
- Inflammatory-marker like C-reactive protein (CRP) level
Exploratory
Explanatory
Not applicable
HYPOTHESIS - ACCEPTED
1. Vitamin D supplementation for 12 weeks would improve glycemic indices of HbA1c among Type 2 diabetic patients as compared to placebo group
2. Vitamin D supplementation for 12 weeks would improve glycemic indices of fasting blood glucose among Type 2 diabetic patients as compared to placebo group
HYPOTHESIS - REJECTED
1. Vitamin D supplementation for 12 weeks would improve fasting Plasma Insulin.
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Prevention
Medicine | Food | Behavior,custom |
Vitamin D Supplementation
Placebo
30 | years-old | <= |
70 | years-old | >= |
Male and Female
1. Type 2 diabetic patients of aged 30 year to 70 year who were in treatment of oral hypoglycemic agent.
2. Agreed to maintain their usual dietary and physical activity habits at the time of intervention.
3. Voluntarily willing to participate in this clinical study.
1. Below 30 years or above 70 years of age with Type I Diabetes Mellitus on insulin
2. Consuming vitamin D supplements within 3 months before beginning of the study
3. Women patients who were pregnant or breastfeeding
146
1st name | Nadia |
Middle name | |
Last name | Begum |
University of Dhaka, Bangladesh
Institute of Nutrition and Food Science
1207
Apartment No. 3A, House No. 409, Road No. 5, Adabor, Dhaka, Bangladesh
+8801712929996
nadiabegum.zhs@gmail.com
1st name | Nadia |
Middle name | |
Last name | Begum |
University of Dhaka, Bangladesh
Institute of Nutrition and Food Science
1207
Apartment No. 3A, House No. 409, Road No. 5, Adabor, Dhaka, Bangladesh
+8801712929996
nadiabegum.zhs@gmail.com
University of Dhaka, Bangladesh
University of Dhaka, Bangladesh
Institute of Nutrition and Food Science
Ministry of Science and Technology
Ministry of Science and Technology
Bangabandhu Science and Technology Fellowship Trust
Government offices of other countries
Bangladeshi
Institute of Nutrition and Food Science, University of Dhaka
Dhaka University Campus, Dhaka-1000
+88 02 9661920-73 (Ext 8400, 8401)
infs@du.ac.bd
NO
2022 | Year | 06 | Month | 25 | Day |
Partially published
Completed
2019 | Year | 03 | Month | 28 | Day |
2017 | Year | 01 | Month | 16 | Day |
2019 | Year | 05 | Month | 02 | Day |
2021 | Year | 12 | Month | 30 | Day |
2022 | Year | 06 | Month | 11 | Day |
2022 | Year | 06 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054745